IRIS Accounts Production v24.3.2.46 08937960 director 1.8.23 31.7.24 31.7.24 0 0 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh089379602023-07-31089379602024-07-31089379602023-08-012024-07-31089379602022-07-31089379602022-08-012023-07-31089379602023-07-3108937960ns15:EnglandWales2023-08-012024-07-3108937960ns14:PoundSterling2023-08-012024-07-3108937960ns10:Director12023-08-012024-07-3108937960ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3108937960ns10:SmallEntities2023-08-012024-07-3108937960ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3108937960ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3108937960ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3108937960ns10:AbridgedAccounts2023-08-012024-07-3108937960ns10:RegisteredOffice2023-08-012024-07-3108937960ns5:CurrentFinancialInstruments2024-07-3108937960ns5:CurrentFinancialInstruments2023-07-3108937960ns5:Non-currentFinancialInstruments2024-07-3108937960ns5:Non-currentFinancialInstruments2023-07-3108937960ns5:ShareCapital2024-07-3108937960ns5:ShareCapital2023-07-3108937960ns5:RetainedEarningsAccumulatedLosses2024-07-3108937960ns5:RetainedEarningsAccumulatedLosses2023-07-31
REGISTERED NUMBER: 08937960 (England and Wales)











Unaudited Financial Statements

for the Year Ended 31st July 2024

for

Dr Weils Limited

Dr Weils Limited (Registered number: 08937960)






Contents of the Financial Statements
for the Year Ended 31st July 2024




Page

Company Information 1

Abridged Balance Sheet 2

Notes to the Financial Statements 4


Dr Weils Limited

Company Information
for the Year Ended 31st July 2024







DIRECTOR: H Garner





REGISTERED OFFICE: Castle House
High Street
Ammanford
Dyfed
SA18 2NB





REGISTERED NUMBER: 08937960 (England and Wales)





ACCOUNTANTS: Ashmole & Co
Chartered Certified Accountants
Castle House
High Street
Ammanford
Carmarthenshire
SA18 2NB

Dr Weils Limited (Registered number: 08937960)

Abridged Balance Sheet
31st July 2024

31.7.24 31.7.23
£    £   
CURRENT ASSETS
Stocks 4,234 5,692
Debtors 9,143 3,132
13,377 8,824
CREDITORS
Amounts falling due within one year (12,459 ) (7,692 )
NET CURRENT ASSETS 918 1,132
TOTAL ASSETS LESS CURRENT LIABILITIES 918 1,132

CREDITORS
Amounts falling due after more than one
year

(3,467

)

(4,190

)
NET LIABILITIES (2,549 ) (3,058 )

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings (2,649 ) (3,158 )
SHAREHOLDERS' FUNDS (2,549 ) (3,058 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Dr Weils Limited (Registered number: 08937960)

Abridged Balance Sheet - continued
31st July 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

All the members have consented to the preparation of an abridged Balance Sheet for the year ended 31st July 2024 in accordance with Section 444(2A) of the Companies Act 2006.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 10th March 2025 and were signed by:





H Garner - Director


Dr Weils Limited (Registered number: 08937960)

Notes to the Financial Statements
for the Year Ended 31st July 2024

1. STATUTORY INFORMATION

Dr Weils Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

These accounts have been prepared under the going concern basis.

The company is dependent on financial support received from the director.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Dr Weils Limited (Registered number: 08937960)

Notes to the Financial Statements - continued
for the Year Ended 31st July 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2023 - NIL).

4. GOING CONCERN

At the balance sheet date the company's liabilities exceeded its assets. The company has received assurance from the directors that they will continue to give financial support to the company for twelve months from the date of signing the financial statements.

On this basis the directors consider it appropriate to prepare the accounts on a going concern basis. However, should the financial support mentioned above not be forthcoming, the going concern basis used in preparing the company's accounts may be invalid and adjustments would have to be made to reduce the value of assets to their realisable amount and to provide for any further liabilities which may arise. The accounts do not include any adjustments to the company's assets or liabilities that might be necessary should this basis not continue.